These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3732527)
1. Hormone excretion during early pregnancy following spontaneous and clomiphene citrate-induced ovulation. Strigini F; Collins WP; Whitehead MI; Benedetto Melis G; Fioretti P; Campbell S Fertil Steril; 1986 Aug; 46(2):209-14. PubMed ID: 3732527 [TBL] [Abstract][Full Text] [Related]
2. The effect of conception on the concentration of urinary oestrone-3-glucuronide, LH/hCG and pregnanediol-3 alpha-glucuronide. Branch CM; Collins PO; Kilpatrick MJ; Collins WP Acta Endocrinol (Copenh); 1980 Feb; 93(2):228-33. PubMed ID: 7376791 [TBL] [Abstract][Full Text] [Related]
3. Excretion of estrone-3-glucuronide in urine in spontaneous and induced ovulatory cycles. Khatkhatay MI; Sankolli GM; Meherji PK; Chowdhury V; Joshi UM Int J Fertil; 1988; 33(3):181-7. PubMed ID: 2899564 [TBL] [Abstract][Full Text] [Related]
4. The prediction and/or detection of ovulation by means of urinary steroid assays. Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775 [TBL] [Abstract][Full Text] [Related]
5. Urinary estrone glucuronide, pregnanediol glucuronide and human chorionic gonadotrophin in threatened abortion. Ishwad PC; Chitlange SM; Joshi UM; Chowdhury V; Mehta AC Int J Gynaecol Obstet; 1988 Aug; 27(1):107-11. PubMed ID: 2905284 [TBL] [Abstract][Full Text] [Related]
7. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles. Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744 [TBL] [Abstract][Full Text] [Related]
8. The OVEIA assay, a simultaneous measurement of oestrone and pregnanediol glucuronides, for studying the treatment of infertility patients. Anthony F; Aldrich C; Sharp NC; Smith EM; Masson GM; Dennis KJ Hum Reprod; 1988 Oct; 3(7):870-2. PubMed ID: 3182977 [TBL] [Abstract][Full Text] [Related]
9. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation. Croxatto HB; Salvatierra AM; Romero C; Spitz IM J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656 [TBL] [Abstract][Full Text] [Related]
11. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin. Cameron IT; Baird DT Acta Endocrinol (Copenh); 1988 Jun; 118(2):161-7. PubMed ID: 3291533 [TBL] [Abstract][Full Text] [Related]
12. Urinary hormone levels at the time of ovulation and implantation. Lasley BL; Stabenfeldt GH; Overstreet JW; Hanson FW; Czekala N; Munro C Fertil Steril; 1985 Jun; 43(6):861-7. PubMed ID: 3996630 [TBL] [Abstract][Full Text] [Related]
13. Corpus luteum function and pregnancy rates with clomiphene citrate therapy: comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation. Agarwal SK; Buyalos RP Hum Reprod; 1995 Feb; 10(2):328-31. PubMed ID: 7769057 [TBL] [Abstract][Full Text] [Related]
14. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles. Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724 [TBL] [Abstract][Full Text] [Related]
15. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function. Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920 [TBL] [Abstract][Full Text] [Related]
16. The luteal phase after hyperstimulation for in vitro fertilization. Gronow MJ; Martin MJ; Hay D; Moro D; Brown JB Ann N Y Acad Sci; 1985; 442():391-401. PubMed ID: 3160279 [TBL] [Abstract][Full Text] [Related]
17. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function. Magini A; Pinzani P; Bolelli GF; Bassi F; Salerno R; Messeri G; Pazzagli M J Biolumin Chemilumin; 1989 Jul; 4(1):567-74. PubMed ID: 2801241 [TBL] [Abstract][Full Text] [Related]
18. Induction of ovulation. An attempt to avoid complications. Cox LW; Cox RI; Black TL Am J Obstet Gynecol; 1968 Sep; 102(2):177-85. PubMed ID: 5675863 [No Abstract] [Full Text] [Related]
19. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles. Adekunle AO; Collins WP; Whitehead MI Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021 [TBL] [Abstract][Full Text] [Related]
20. Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function. Yilmaz B; Kelekci S; Savan K; Oral H; Mollamahmutoglu L Fertil Steril; 2006 Mar; 85(3):783-6. PubMed ID: 16500364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]